VYNT
Vyant Bio, Inc. Common Stock
VYNT
VYNT
Delisted
VYNT was delisted on the 12th of May, 2023.
25 hedge funds and large institutions have $9.2M invested in Vyant Bio, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.3M | |
| 2 | +$339K | |
| 3 | +$131K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$98.1K |
| 5 |
Squarepoint
New York
|
+$36K |
Top Sellers
| 1 | -$230K | |
| 2 | -$103K | |
| 3 | -$91.9K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$66K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$44.5K |